Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fabris

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|April 19, 2008
Impact of HIV on host-virus interactions during early hepatitis C virus infectionM Danta, N Semmo, P Fabris, et al.
Journal of Gastroenterology|August 5, 1999
Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFNP Fabris, F Marranconi, L Bozzola, et al.
Infection|October 31, 1998
HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis CP Fabris, M R Biasin, D Infantolino, et al.
Haematologica|December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical studyR Bassan, E Pogliani, T Lerede, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Clinical sensitivity to anthracyclines in PH/BCR+ acute lymphoblastic leukemiaR Bassan, A Z Rohatiner, A Rambaldi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in ItalyT Santantonio, E Medda, C Ferrari, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemiaR Bassan, A Z Rohatiner, T Lerede, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groupsR Bassan, E Pogliani, P Casula, et al.
British Journal of Haematology|November 25, 2000
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'AdultoM Montillo, A Tedeschi, L Pagano, et al.
Minerva Urologica|October 1, 1982
[Sodium cefoxitin in urology. Polycentric clinical study]T Lotti, A Altieri, P Baccarani, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|April 19, 2008
Impact of HIV on host-virus interactions during early hepatitis C virus infectionM Danta, N Semmo, P Fabris, et al.
Journal of Gastroenterology|August 5, 1999
Fibrogenesis serum markers in patients with chronic hepatitis C treated with alpha-IFNP Fabris, F Marranconi, L Bozzola, et al.
Infection|October 31, 1998
HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis CP Fabris, M R Biasin, D Infantolino, et al.
Haematologica|December 10, 1999
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical studyR Bassan, E Pogliani, T Lerede, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Clinical sensitivity to anthracyclines in PH/BCR+ acute lymphoblastic leukemiaR Bassan, A Z Rohatiner, A Rambaldi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2006
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in ItalyT Santantonio, E Medda, C Ferrari, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemiaR Bassan, A Z Rohatiner, T Lerede, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groupsR Bassan, E Pogliani, P Casula, et al.
British Journal of Haematology|November 25, 2000
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'AdultoM Montillo, A Tedeschi, L Pagano, et al.
Minerva Urologica|October 1, 1982
[Sodium cefoxitin in urology. Polycentric clinical study]T Lotti, A Altieri, P Baccarani, et al.
Pageof 8